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1. Introduction 
Superoxide dismutase (SOD) is believed to play a 
key role in the enzymatic defence of the cell against 
oxygen toxicity, the belief being substantiated by the 
ubiquitous presence of this enzyme in aerobic orga- 
nisms and by an impressive body of evidence for a 
protective role of SOD both in vitro and in vivo (cf. 
reviews [1,2] ). 
It was of obvious interest o study SOD activity 
in tumors. Dionisi et al. [3] reported SOD to be 
absent from tumor mitochondria. On the other hand, 
our preliminary data [4] and recent results of Rotiho 
and collaborators [S] pointed to a low SOD activity 
in the cytosol of tumor cells. In this communication 
we confirm and extend our preliminary observations 
showing tumors to be poor in cytosolic cyanide- 
sensitive SOD, compared to normal tissues. 
In addition, a decline in the SOD activity of the 
Hepatoma 27 mitochondria (as compared to liver 
mitochondria) is found to be due solely to a lower 
content of the cytoplasmic-type Cu-Zn-enzyme 
localized in the intermembrane space of mitochondria; 
no change in the eumitochondrial cyanide-insensitive 
enzymatic SOD activity could be observed. The 
activity of glutathione peroxidase (GP), another 
enzyme thought o be ‘the first line of defence agsinst 
oxidative damage’ [6-81, was relatively very low in 
both cytosol and mitochondrial matrix of Hepatoma 
27, suggesting the presence of a single enzyme in these 
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two cell compartments rather than of two differently 
controlled isoenzymes. 
2. Methods 
2.1. Experimental tumors 
These were grown as outlined in the table 1. 
2.2.77re SOD assay 
The standard method of Beauchamp and Fridovich 
(91 was used (xanthine oxidase/Nitro Blue Tetra- 
zolium (NBT)) with the only modification being that 
the temperature was 3O*C. Linear rates of BIue 
Formazan accumulation were monitored with a 
‘Unicam SP 8000 recording spectrophotometer at 
560 nm. 
2.3. The SOD activity in cytosol 
Tumors or normal tissues were minced thoroughly 
with scissors and homogenized in a Potter-Elvehjem 
homogenizer in a medium containing 0.25 M sucrose, 
0.01 M Tris-HCl, pH 7.5. The homogenate was 
centrifuged for 1 h at 105 000 X g. The resulting clear 
supernatant was referred as the “cytosolic’ fraction. 
2 .4.?%e SOD activie in mitochondria 
Mitochondria were isolated from rat liver and 
Hepatoma 27 by a conventional procedure [lo] with 
slight modification and the purity of the fmal prepa- 
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Table 1 
Conditions of tumor growth 
Tumor 
Hepatoma 27 
Zajdela hepatoma 
Walker 256 carcino- 
sarcoma 
Adenocarcinoma 755 
Sarcoma 180 
Ehrlich ascites carcinoma 
Lewis lung carcinoma 
Random-bred albino rats 
Random-bred albino rats 
Random-bred aIbino rats 
C57Bl mice 
Random-bred albino mice 
C57Bl X CBAmice 
C57Bl mice 
ration was monitored by electron microscopy. Mito- 
chondria were sonicated for 2 X 15 s in an MSE 
ultrasonic disintegrator, type I667 (20 kcycles/s, 
maximal output) and then centrifuged at 105 000 X g 
for 1 h. The supernatant was assayed for SOD. The 
cyanide-insensitive SOD was determined in the 
presence of 1 mM cyanide in the reaction mixture. 
2.5 . The SOD activity in mitochondrial matrix 
Prior to sonication, mitochondria were osmotically 
shocked (20 min in 10 mM Tris-HCl, pH 7.5) to 
disrupt he outer membrane and washed to remove 
the soluble intermembrane enzymes. 
The NBT-reductase activity was checked carefully 
Time of growth 
3-4 weeks Subcutaneous 
1 week Intraperitoneal 
2 weeks 
2 weeks 
11 days 
1 week 
10 days 
Route of 
transplantation 
Subcutaneous 
Subcutaneous 
Subcutaneous 
Intraperitoneal 
Intramuscular 
in all samples and found to be negligible or absent in 
the cytosolic fractions. ‘Mitochondrial’ supernatants 
reduced NBT, but, too slowly to interfere significantly 
with the SOD assays and could be easily compensated 
by adding aliquots of the sample being assayed for 
SOD to both the sample and the reference cells. 
GP activity was measured according to [ 1 I] in the 
same fractions as SOD. 
3. Results 
A survey of the SOD activity in the cytosolic 
fractions of various rat and mouse normal and tumor 
tissues is presented in table 2. All the activities listed 
Table 2 
Cytosolic SOD activity in tumors and normal tissues 
Tissue Animals Specific activitya 
(units/mg protein 
of the ‘cytosolic’ fraction) 
Liver 
Liver 
Lung 
Heart 
Spleen 
Brain 
Rats 
Mice 
Mice 
Mice 
Mice 
Mice 
180+ 17 (6) 
240 f 50 (7) 
120 f 26 (4) 
67 f 16 (3) 
62 * 20 (2) 
91 + 20 (2) 
Activitya 
(units/g tissue) 
10 800 f 1100 (6) 
15 lo0 * 3200 (7) 
4400 f 200 (4) 
2400 f 400 (3) 
3100 f 100 (2) 
1900 * 400 (2) 
Walker 256 carcinosarcoma Rats 25 ?: 6 (4) 640 * 90 (4) 
Zajdela hepatoma Rats 17 + 1 (2) 420? 10 (2) 
Hepatoma 27 Rats 36 f 4 (6) 2000 f 200 (6) 
Lewis lung carcinoma Mice 24 * 4 (3) 610+ 40 (3) 
Sarcoma 180 Mice 26 + 1 (2) 990 + 40 (2) 
Adenocarcinoma 755 Mice 11 (1) 500 (1) 
Ehrlich ascites carcinoma Mice 15 (1) 240 (1) 
a Averages * SD are given for the indicated number of experiments 
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in table 2 were more than 95% sensitive to KCN and 
heat treatment. In agreement with the data of others’ 
[ 12,131, liver is found to be richest in SOD. Heart, 
lungs, brain and spleen specific activities (left column) 
were not very much different from each other (OS- 
0.25 that of liver). The ratios of total activities (right 
column) are roughly similar but the difference between 
liver and other tissues is even more pronounced. A
somewhat lower total SOD activity in brain tissue is 
probably due to a relatively smaller partial volume of 
cytoplasm in brain cells. 
It may be seen that tumors are characterized by 
considerably ower cytosolic SOD activity. Thus for 
Hepatoma 27, Zajdela hepatoma nd Lewis lung 
carcinoma the ratios of the specific SOD activities to 
those in the homologous tissues (liver [14,15] and 
lung [ 163 ) are 0.1-0.2. Decreased SOD activity was 
not observed in our preliminary experiments on 
regenerating orpost-natal developing rat liver and 
therefore it may be a characteristic of neoplastic 
growth rather than of proliferation or differentiation. 
Dionisi et al. [3] claimed recently that it was ‘a 
general feature of tumor mitochondria not to possess 
superoxide dismutase’. We found the specific SOD 
activity in mitochondria from Hepatoma 27 to be 
about 3.5-fold lower than in liver mitochondria 
(table 3), apparently in agreement with the data of 
Dionisi et al. [3 ] on Morris hepatoma. However, 
in the presence of cyanide, both tumor and liver 
mitochondria displayed rather similar specific SOD 
activities (sensitive to heat treatment) of approximately 
2-3 units/mg protein. 
The values of 9 and 11 units/mg protein were 
obtained for Hepatoma 27 and liver mitochondrial 
cyanide-insensitive SOD activities respectively when 
higher salt concentrations were present in the 
sonication medium, in agreement with the data on 
mitochondrial SOD being ‘loosely bound’ to the 
membrane [ 12,171. It was further found that in 
osmotically shocked and washed mitochondria from 
Hepatoma 27 and liver the remaining SOD activity 
was cyanide-insensitive and again similar for both 
tissues. 
These results clearly show that a net decrease in 
Hepatoma 27 mitochondrial SOD activity merely 
follows the decline of the cytosolic cyanide-sensitive 
Cu-Zn-type enzyme localized in the intermembrane 
space of mitochondria [12,17-191. 
Evidently, there is no pronounced change in the 
level of the true mitochondrial procaryotic-type 
cyanide-insensitive enzyme. The same explanation is 
probably applicable to the data of Dionisi et al. [3] 
since those authors did not report sensitivity of mito- 
chondrial SOD to cyanide in their experiments. 
GP is also believed to be of primary importance 
for cell protection against oxidative damage [5-71. 
Like SOD, GP is present in both cytosol and mito- 
chondrial matrix [20] . However, there are not two 
entirely different isoenzymes as with SOD but rather 
a single enzyme in both cell compartments [20] . It 
was therefore of interest o compare the behaviour of 
GP and SOD upon neoplastic transformation. It may 
be seen (table 4) that the GP activity is drastically 
decreased not only in the cytosolic fraction of 
Hepatoma 27, but in the mitochondrial matrix as well. 
Thus GP intramitochondrial compartmentalization per 
se does not prevent its response to malignancy. 
4. Discus.sion 
It would be premature to speculate on the 
Table 3 
SOD activity in mitochondria from rat liver and Hepatoma 27 
Specific activity (units/mg protein)a 
Tissue Without shock Osmotically shocked 
-CN- +CN- -CN- +CN- 
Liver 34 f 8 (5) 3.0 f 1.3 (4) 2.9 f 0.5 (4) 1.3 f 0.1 (4) 
Hepatoma 27 10 f 2.4 (7) 2.0 f 0.2 (7) 2.4 + 0.9 (3) 2.1 f 0.4 (4) 
a See footnote to table 2 
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Table 4 
GP activity in liver and Hepatoma 27 
June 1971 
Tissue Specific activitya (units/mg protein)a 
Cytosol Mitochondria 
Without shock Osmotically shocked 
Liver 159 * 24 (6) 188 f 42 (4) 108 * 5 (3) 
Hepatoma 27 15 f 3 (12) 8.5 f 2.3 (4) 8.5 i 2.3 (5) 
a See footnote to table 2 
‘sufficiency’ or ‘insufficiency’ of the low SOD activity 
in tumors, since there are not sufficient data on the 
actual rates of Oj production in tumor cells. A 
greatly reduced enzymatic defence system against 
oxygen toxicity and a concomitant enrichment in 
antioxidants [21] may, however, indicate that 
cancetous tissues are ‘switched’ to a more primitive 
chemical mechanism of oxygen detoxication than the 
enzymatic one. 
On the other hand, diminished activity of SOD, 
GP, catalase [22] and, possibly, other oxygen-pro- 
tective enzymes in neoplastic tissues can arise from 
the general trend of tumors to decreased aerobic meta- 
bolism. Interestingly, the level of xanthine oxidase, 
which is known to be a potent generator of Oj 
radicals, is low in tumors [23] . 
Quite apart from the above considerations, data on 
SOD a&v&y in cancer tissues hould be of practical 
significance for cancer adiotherapy. Oj Radical was 
shown to play an important role in oxygen enhance- 
ment of radiation damage [24-261. Radioprotective 
functions of SOD have been demonstrated both in 
&ro [27-291 and in vivo [30]. The low level of SOD 
in tumors compared to that in normal tissues could 
account at least partially for the positive ffect of 
hyperbaric oxygen on the effectiveness of y-therapy 
[3 1,321. Data on SOD activity in human tumors 
(experiments inprogress) would be of particular 
importance on this point. 
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